VRHI (Veri Medtech Holdings) Receivables Turnover: 0.00 (As of Dec. 2021)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

VRHI Veri Medtech Holdings Inc VRHI
35 GF Score
Price $2.00
View Full Analysis

What is Veri Medtech Holdings Receivables Turnover?

Veri Medtech Holdings VRHI 35 Receivables Turnover is 0.00 as of Dec. 2021. GuruFocus rates VRHI with a GF Score™ of 35/100.

The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Veri Medtech Holdings's Revenue for the six months ended in Dec. 2021 was $0.05 Mil. Veri Medtech Holdings's average Accounts Receivable for the six months ended in Dec. 2021 was $0.00 Mil.


Veri Medtech Holdings  (OTCPK:VRHI) Receivables Turnover Explanation

An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.


Veri Medtech Holdings Receivables Turnover Related Terms


Veri Medtech Holdings Receivables Turnover Historical Data

* Premium members only.

The historical data trend for Veri Medtech Holdings's Receivables Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Veri Medtech Holdings Receivables Turnover Chart

Veri Medtech Holdings Annual Data
Trend Dec21
Receivables Turnover
0.00

Veri Medtech Holdings Semi-Annual Data
Dec21
Receivables Turnover 0.00

VRHI vs MMVVF, BLMZ, MVNC: Receivables Turnover Comparison

For the Health Information Services subindustry, Veri Medtech Holdings's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Veri Medtech Holdings Receivables Turnover vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Veri Medtech Holdings's Receivables Turnover distribution charts can be found below:

* The bar in red indicates where Veri Medtech Holdings's Receivables Turnover falls into.


VRHI
35GF Score
Veri Medtech Holdings Inc VRHI
Receivables Turnover is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Veri Medtech Holdings Receivables Turnover Calculation

Receivables Turnover measures the number of times a company collects its average accounts receivable balance.

Veri Medtech Holdings's Receivables Turnover for the fiscal year that ended in Dec. 2021 is calculated as

Receivables Turnover (A: Dec. 2021 )
=Revenue / Average Accounts Receivable
=Revenue (A: Dec. 2021 ) / ((Accounts Receivable (A: . 20 ) + Accounts Receivable (A: Dec. 2021 )) / count )
=0.049 / (( + 0) / 1 )
=0.049 / 0
=N/A

Veri Medtech Holdings's Receivables Turnover for the quarter that ended in Dec. 2021 is calculated as

Receivables Turnover (Q: Dec. 2021 )
=Revenue / Average Accounts Receivable
=Revenue (Q: Dec. 2021 ) / ((Accounts Receivable (Q: . 20 ) + Accounts Receivable (Q: Dec. 2021 )) / count )
=0.049 / (( + 0) / 1 )
=0.049 / 0
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Receivables Turnover →
What does a Receivables Turnover of 0.00 mean?
Veri Medtech Holdings (VRHI) has a Receivables Turnover of 0.00 as of Dec. 2021. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Veri Medtech Holdings and its competitors.
Is Veri Medtech Holdings' Receivables Turnover too high?
Veri Medtech Holdings' current Receivables Turnover is 0.00. Overall, Veri Medtech Holdings has a GF Score™ of 35/100, reflecting its overall financial health beyond just this single metric.
How does Veri Medtech Holdings' Receivables Turnover compare to MMVVF and BLMZ?
Veri Medtech Holdings' Receivables Turnover of 0.00 can be compared against companies in the Healthcare Providers & Services industry. The industry median Receivables Turnover is 7.75. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Healthcare Providers & Services company?
The median Receivables Turnover among Healthcare Providers & Services companies is 7.75, based on 659 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Veri Medtech Holdings and its competitors. For the Healthcare Providers & Services industry, the median Receivables Turnover is 7.75 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Veri Medtech Holdings's current Receivables Turnover is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Veri Medtech Holdings stock overvalued right now?
Veri Medtech Holdings (VRHI) has a current Receivables Turnover of 0.00. The current Receivables Turnover is 0.00. Veri Medtech Holdings' overall GF Score™ is 35/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For Veri Medtech Holdings (VRHI), the current Receivables Turnover is 0.00 as of Dec. 2021. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Veri Medtech Holdings Business Description

Address 1660 International Drive, Suite 600, McClean, VA, USA, 22101
Veri Medtech Holdings Inc is a healthcare technology company that offers alternative medicine, personalized diagnostics, and wellness medication on demand. The company leverages telehealth infrastructure, diagnostic intelligence, and scalable digital systems to meet the growing demand for accessible, stigma-free healthcare. Strategically positioned for growth, Veri MedTech actively explores acquisitions that complement its core capabilities and enhance patient engagement across emerging sectors of alternative medicine, longevity, and wellness science. With an integration and operational efficiency track record, the company drives accelerated revenue through the continuous generation of high-value patient databases and recurring service models.
35GF Score

Get the complete analysis for VRHI

Receivables Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.00
Price